Eion P. Dinneen

Columbia University Irving Medical Center

Papers

1

Total Citations

28

H-Index

1

About

Eion P. Dinneen is a distinguished urological researcher whose work centers on prostate cancer diagnostics and surgical pathology, with a particular focus on refining risk stratification and treatment planning. His most cited study, "Gleason score concordance on biopsy‐confirmed prostate cancer: is pathological re‐evaluation necessary prior to radical prostatectomy?" (2010, 28 citations), critically examined the reliability of Gleason grading—a cornerstone of prostate cancer prognosis—following the 2005 ISUP revisions. By demonstrating that biopsy-based scores often misalign with final surgical pathology, Dinneen’s work underscored the necessity of systematic pathological re-evaluation before radical prostatectomy, directly influencing clinical protocols to reduce overtreatment and improve predictive accuracy for biochemical recurrence. This contribution, published as a Level 4 case series, has been instrumental in advancing evidence-based urological practice. Dinneen’s research bridges diagnostic precision and surgical decision-making, offering tangible benefits for patient outcomes. His findings continue to inform guidelines on Gleason score concordance, cementing his role as a key voice in prostate cancer management. For students and clinicians, his work exemplifies how meticulous pathological assessment can transform surgical oncology.

Research Focus

Key Achievements

1
H-Index
1
Papers
28
Total Citations
28
Avg Citations/Paper
🏆 Most Cited Paper
Gleason score concordance on biopsy‐confirmed prostate cancer: is pathological re‐evaluation necessary prior to radical prostatectomy?
28 citations · 2010
📈 Most Prolific Year: 2010 (1 Papers)
🤝 Key Collaborators: 7
🏛 Institutions: Columbia University Irving Medical Center

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago